Literature DB >> 7643139

Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA.

C Mariotti1, N Savarese, A Suomalainen, M Rimoldi, G Comi, A Prelle, C Antozzi, S Servidei, L Jarre, S DiDonato, M Zeviani.   

Abstract

We studied 22 subjects carrying the A3243G point mutation of human mitochondrial DNA (mtDNA). In 14 cases the clinical phenotype was characterized by mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), while 8 patients had chronic progressive external ophthalmoplegia (CPEO). The proportion of A3243G heteroplasmy in muscle was determined by two methods; densitometry on a diagnostic restriction-fragment length polymorphism and solid-phase mini-sequencing. We found a highly significant inverse correlation between the percentage of A3243G mutation and the specific activity of complex I, the respiratory complex with the highest number of mtDNA-encoded subunits, suggesting a direct effect of the mutation on mtDNA translation. No correlation was observed between the percentage of mutated mtDNA and the presence or absence of specific clinical features, such as stroke, ophthalmoplegia and diabetes mellitus. However, in the MELAS group the percentage of mutated mtDNA molecules was strongly correlated with the age of onset, while no such correlation was found in the CPEO group, suggesting a different time-dependent evolution of the mutation in the two groups. Finally, in contrast with other mtDNA mutations associated with ragged-red fibres (RRF), in both MELAS3243 and CPEO3243 we observed a high proportion of RRF that were positive to the histochemical reaction to cytochrome c oxidase, a morphological feature that seems to be specific for the neuromuscular phenotypes associated with mutations affecting the tRNA(Leu(UUR)) gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643139     DOI: 10.1007/BF00878873

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

2.  A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.

Authors:  I J Holt; A E Harding; R K Petty; J A Morgan-Hughes
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

3.  Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples.

Authors:  S R Hammans; M G Sweeney; M Brockington; J A Morgan-Hughes; A E Harding
Journal:  Lancet       Date:  1991-06-01       Impact factor: 79.321

4.  Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot?

Authors:  C T Moraes; F Ciacci; E Bonilla; C Jansen; M Hirano; N Rao; R E Lovelace; L P Rowland; E A Schon; S DiMauro
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

5.  Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243.

Authors:  V Petruzzella; C T Moraes; M C Sano; E Bonilla; S DiMauro; E A Schon
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

6.  A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene.

Authors:  M Zeviani; F Muntoni; N Savarese; G Serra; V Tiranti; F Carrara; C Mariotti; S DiDonato
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

7.  Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.

Authors:  Y Tatuch; J Christodoulou; A Feigenbaum; J T Clarke; J Wherret; C Smith; N Rudd; R Petrova-Benedict; B H Robinson
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

8.  Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Authors:  M P King; Y Koga; M Davidson; E A Schon
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

Review 9.  Defects of mitochondrial DNA.

Authors:  M Zeviani; C Antozzi
Journal:  Brain Pathol       Date:  1992-04       Impact factor: 6.508

10.  Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy.

Authors:  M Sciacco; E Bonilla; E A Schon; S DiMauro; C T Moraes
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

View more
  17 in total

Review 1.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Tissue specific distribution of the 3243A->G mtDNA mutation.

Authors:  A L Frederiksen; P H Andersen; K O Kyvik; T D Jeppesen; J Vissing; M Schwartz
Journal:  J Med Genet       Date:  2006-02-20       Impact factor: 6.318

3.  Acute pancreatitis in an infant with lactic acidosis and a mutation at nucleotide 3243 in the mitochondrial DNA tRNALeu(UUR) gene.

Authors:  P S Kishnani; J L Van Hove; J S Shoffner; A Kaufman; E H Bossen; S G Kahler
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

4.  Heterogeneous presentation in A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  Y Koga; Y Akita; N Takane; Y Sato; H Kato
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

5.  The A to G transition at nt 3243 of the mitochondrial tRNALeu(UUR) may cause an MERRF syndrome.

Authors:  G M Fabrizi; E Cardaioli; G S Grieco; T Cavallaro; A Malandrini; L Manneschi; M T Dotti; A Federico; G Guazzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

6.  Identification and minisequencing-based discrimination of SHV beta-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, Australia.

Authors:  Christopher Howard; Angela van Daal; Gregory Kelly; Jacqueline Schooneveldt; Graeme Nimmo; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 7.  Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients.

Authors:  Sara Bonazza; Chiara La Morgia; Paolo Martinelli; Sabina Capellari
Journal:  Neurol Sci       Date:  2011-04-09       Impact factor: 3.307

Review 8.  Energetic depression caused by mitochondrial dysfunction.

Authors:  Frank Norbert Gellerich; Sonata Trumbeckaite; Tobias Müller; Marcus Deschauer; Ying Chen; Zemfira Gizatullina; Stephan Zierz
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

9.  Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population.

Authors:  K Majamaa; J S Moilanen; S Uimonen; A M Remes; P I Salmela; M Kärppä; K A Majamaa-Voltti; H Rusanen; M Sorri; K J Peuhkurinen; I E Hassinen
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

10.  Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.

Authors:  Raj K Gopal; Kirsten Kübler; Sarah E Calvo; Paz Polak; Dimitri Livitz; Daniel Rosebrock; Peter M Sadow; Braidie Campbell; Samuel E Donovan; Salma Amin; Benjamin J Gigliotti; Zenon Grabarek; Julian M Hess; Chip Stewart; Lior Z Braunstein; Peter F Arndt; Scott Mordecai; Angela R Shih; Frances Chaves; Tiannan Zhan; Carrie C Lubitz; Jiwoong Kim; A John Iafrate; Lori Wirth; Sareh Parangi; Ignaty Leshchiner; Gilbert H Daniels; Vamsi K Mootha; Dora Dias-Santagata; Gad Getz; David G McFadden
Journal:  Cancer Cell       Date:  2018-08-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.